Causative and susceptibility genes for Alzheimer's disease: a review
- PMID: 12788204
- DOI: 10.1016/s0361-9230(03)00067-4
Causative and susceptibility genes for Alzheimer's disease: a review
Abstract
Alzheimer's disease (AD) is the most common type of dementia in the elderly population. Three genes have been identified as responsible for the rare early-onset familial form of the disease: the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene and the presenilin 2 (PSEN2) gene. Mutations in these genes, however, account for less than 5% of the total number of AD cases. The remaining 95% of AD patients are mostly sporadic late-onset cases, with a complex aetiology due to interactions between environmental conditions and genetic features of the individual. In this paper, we review the most important genes supposed to be involved in the pathogenesis of AD, known as susceptibility genes, in an attempt to provide a comprehensive picture of what is known about the genetic mechanisms underlying the onset and progression of AD. Hypotheses about the role of each gene in the pathogenic pathway are discussed, taking into account the functions and molecular features, if known, of the coded protein. A major susceptibility gene, the apolipoprotein E (APOE) gene, found to be associated with sporadic late-onset AD cases and the only one, whose role in AD has been confirmed in numerous studies, will be included in a specific chapter. As the results reported by association studies are conflicting, we conclude that a better understanding of the complex aetiology that underlies AD may be achieved likely through a multidisciplinary approach that combines clinical and neurophysiological characterization of AD subtypes and in vivo functional brain imaging studies with molecular investigations of genetic components.
Similar articles
-
[Genes in Alzheimer's disease].Rev Neurol. 2006 Mar 1-15;42(5):302-5. Rev Neurol. 2006. PMID: 16538594 Review. Spanish.
-
New frontiers in Alzheimer's disease genetics.Neuron. 2001 Oct 25;32(2):181-4. doi: 10.1016/s0896-6273(01)00476-7. Neuron. 2001. PMID: 11683989 Review.
-
Genetics of Alzheimer's disease.Arch Med Res. 2012 Nov;43(8):622-31. doi: 10.1016/j.arcmed.2012.10.017. Epub 2012 Nov 8. Arch Med Res. 2012. PMID: 23142261 Review.
-
Molecular genetics of Alzheimer's disease.Ann Med. 1998 Dec;30(6):560-5. doi: 10.3109/07853899809002605. Ann Med. 1998. PMID: 9920359 Review.
-
Molecular genetics of Alzheimer's disease.Geriatrics. 1997 Sep;52 Suppl 2:S9-12. Geriatrics. 1997. PMID: 9307578 Review.
Cited by
-
The generation and function of soluble apoE receptors in the CNS.Mol Neurodegener. 2006 Oct 24;1:15. doi: 10.1186/1750-1326-1-15. Mol Neurodegener. 2006. PMID: 17062143 Free PMC article.
-
Proteomics in animal models of Alzheimer's and Parkinson's diseases.Ageing Res Rev. 2009 Jan;8(1):1-17. doi: 10.1016/j.arr.2008.07.003. Epub 2008 Jul 18. Ageing Res Rev. 2009. PMID: 18703168 Free PMC article. Review.
-
A retrospective analysis of outpatient anesthesia management for dental treatment of patients with severe Alzheimer's disease.J Dent Anesth Pain Med. 2017 Dec;17(4):271-280. doi: 10.17245/jdapm.2017.17.4.271. Epub 2017 Dec 28. J Dent Anesth Pain Med. 2017. PMID: 29349349 Free PMC article.
-
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.Clin Interv Aging. 2016 Dec 15;11:1817-1822. doi: 10.2147/CIA.S116724. eCollection 2016. Clin Interv Aging. 2016. PMID: 28008242 Free PMC article.
-
Role of curcumin on beta-amyloid protein, tau protein, and biochemical and oxidative changes in streptozotocin-induced diabetic rats.Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9833-9844. doi: 10.1007/s00210-024-03231-3. Epub 2024 Jun 26. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38922352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous